CLNN

Clene (CLNN)

‌

About Clene (CLNN)

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Details

Daily high

$4.59

Daily low

$4.30

Price at open

$4.47

52 Week High

$9.20

52 Week Low

$3.82

Market cap

36.6M

Dividend yield

0.00%

Volume

33,572

Avg. volume

42,892

P/E ratio

-15.76

Clene News